Abbott | ABT - Umsatzkosten

Aktienkurs
105.56
Täglich Wechseln
-1.63 -1.52%
Monatlich
-8.44%
Jährlich
-16.45%
Q1 Prognose
104.77




Umsatzkosten Veränderung Datum
Abbott USD 4.92B 535M 2025-12
Agilent USD 852M 19M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Boston Scientific USD 1.84B 82M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Danaher USD 2.87B 342M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
J&J USD 7.97B 689M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Smith & Nephew USD 870M 17M 2025-12
Solventum Corp USD 971M 8M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12